Michael Yee
Yasmeen Rahimi
Piper Sandler
Roanna Ruiz, Ph.D.
SVB Leerink

Aligos Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Aligos Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Aligos Therapeutics or its management. Aligos Therapeutics does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.